Glycopyrrolate Injection for Non- Depolarising Muscle Relaxants

China Glycopyrrolate Injection for Non- Depolarising Muscle Relaxants, Find details about China Bradycardia, Peripheral Muscarinic from Glycopyrrolate Injection for Non- Depolarising Muscle Relaxants

Model NO.
1ml: 0.2mg
Application
Internal Medicine
Usage Mode
for External Use
Suitable for
Elderly, Children, Adult
Shape
IV
Pharmaceutical Technology
Chemical Synthesis
Trademark
Glycopyrrolate Injection
Specification
1ml: 0.2mg
Origin
Qingyuan, Guangdong, China
HS Code
3004909099
Model NO.
1ml: 0.2mg
Application
Internal Medicine
Usage Mode
for External Use
Suitable for
Elderly, Children, Adult
Shape
IV
Pharmaceutical Technology
Chemical Synthesis
Trademark
Glycopyrrolate Injection
Specification
1ml: 0.2mg
Origin
Qingyuan, Guangdong, China
HS Code
3004909099
         This information is only for medical or pharmacy professionals to read.                                

                               
                                             Package insert of Glycopyrrolate Injection


Please read the package insert carefully and use the product according to the guidance of physicians package insert carefully and use the product                                                                         according to the guidance of physicians
  

Name:Glycopyrrolate Injection

Chemical name:3[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl pyrrolidinium bromide


Description:Glycopyrrolate injection is a clear, colorless liquid.


Strength:1ml:0.2mg


Indications:To protect against the peripheral muscarinic actions (such as bradycardia) of anticholinesterases such as
neostigmine, used to reverse neuromuscular blockade produced by non- depolarising muscle relaxants.


 
Dosage and Administration:The glycopyrrolate injection should be inspected visually for particulate matter and discoloration prior to
administration. The glycopyrrolate injection may be administered intravenously without dilution.
Glycopyrrolate antagonizes muscarinic symptoms (e.g., bronchorrhea, bronchospasm,
bradycardia, and
intestinal hypermotility) induced by cholinergic drugs such as the anticholinesterases.



Storage:Protect from light, store at a temperature NMT 25ºC in a closed container

Package:Neutral borosilicate glass ampoule, 5 units / box

Expiry date: 24 months
Standard No.:
YBH14562020 (issued by NMPA)
Registration No.:H202013016 (issued by NMPA)

Manufacturer Manufacturer name: Guangdong Jiabo Pharmaceutical Co., Ltd. Manufacturing address: Bio-Pharmaceutical Park, High &New Technology industries development Zone, Qingyuan City, Guangdong Province
China Postal code: 511517 
Website: jiabopharm.en.made-in-china.com